-
1
-
-
84918775318
-
-
® FDA Biopharmaceutics Review
-
® FDA Biopharmaceutics Review, 2001. http://www.accessdata.fda.gov/drugsatfda-docs/nda/2001/21319-Duagen-biopharmr-P1.pdf.
-
(2001)
-
-
-
2
-
-
84868590237
-
Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions
-
I.H. Beak, and M.S. Kim Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions Chem. Pharm. Bull. 60 2012 1468 1473
-
(2012)
Chem. Pharm. Bull.
, vol.60
, pp. 1468-1473
-
-
Beak, I.H.1
Kim, M.S.2
-
3
-
-
84877921638
-
Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions
-
H. Chauhan, C. Hui-Gu, and E. Atef Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions J. Pharm. Sci. 102 2013 1924 1935
-
(2013)
J. Pharm. Sci.
, vol.102
, pp. 1924-1935
-
-
Chauhan, H.1
Hui-Gu, C.2
Atef, E.3
-
4
-
-
84877765534
-
Formulation and in vivo evaluation of a self-microemulsifying drug delivery system of dutasteride
-
G.H. Choo, S.J. Park, S.J. Hwang, and M.S. Kim Formulation and in vivo evaluation of a self-microemulsifying drug delivery system of dutasteride Drug Res. 63 2013 203 209
-
(2013)
Drug Res.
, vol.63
, pp. 203-209
-
-
Choo, G.H.1
Park, S.J.2
Hwang, S.J.3
Kim, M.S.4
-
5
-
-
2442545242
-
Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor
-
R.V. Clark, D.J. Hermann, G.R. Cunningham, T.H. Wilson, B.B. Morrill, and S. Hobbs Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor J. Clin. Endocrinol. Metab. 89 2004 2179 2184
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 2179-2184
-
-
Clark, R.V.1
Hermann, D.J.2
Cunningham, G.R.3
Wilson, T.H.4
Morrill, B.B.5
Hobbs, S.6
-
6
-
-
0029562489
-
Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects
-
P.P. Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm. Res. 12 1995 1561 1572
-
(1995)
Pharm. Res.
, vol.12
, pp. 1561-1572
-
-
Constantinides, P.P.1
-
7
-
-
57049140409
-
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
-
F. Danhier, N. Lecouturier, B. Vroman, C. Jérôme, J. Marchand-Brynaert, O. Feron, and V. Préat Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation J. Control. Release 133 2009 11 17
-
(2009)
J. Control. Release
, vol.133
, pp. 11-17
-
-
Danhier, F.1
Lecouturier, N.2
Vroman, B.3
Jérôme, C.4
Marchand-Brynaert, J.5
Feron, O.6
Préat, V.7
-
8
-
-
0344012523
-
Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability
-
P. Gao, B.D. Rush, W.P. Pfund, T. Huang, J.M. Bauer, W. Morozowich, M.S. Kuo, and M.J. Hageman Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability J. Pharm. Sci. 92 2003 2386 2398
-
(2003)
J. Pharm. Sci.
, vol.92
, pp. 2386-2398
-
-
Gao, P.1
Rush, B.D.2
Pfund, W.P.3
Huang, T.4
Bauer, J.M.5
Morozowich, W.6
Kuo, M.S.7
Hageman, M.J.8
-
9
-
-
1842589355
-
Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations
-
P. Gao, M.E. Guyton, T. Huang, J.M. Bauer, K.J. Stefanski, and Q. Lu Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations Drug Dev. Ind. Pharm. 30 2004 221 229
-
(2004)
Drug Dev. Ind. Pharm.
, vol.30
, pp. 221-229
-
-
Gao, P.1
Guyton, M.E.2
Huang, T.3
Bauer, J.M.4
Stefanski, K.J.5
Lu, Q.6
-
10
-
-
59849110173
-
Characterization and optimization of AMG 517 supersaturable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption
-
P. Gao, A. Akrami, F. Alvarez, J. Hu, L. Li, C. Ma, and S. Surapaneni Characterization and optimization of AMG 517 supersaturable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption J. Pharm. Sci. 98 2009 516 528
-
(2009)
J. Pharm. Sci.
, vol.98
, pp. 516-528
-
-
Gao, P.1
Akrami, A.2
Alvarez, F.3
Hu, J.4
Li, L.5
Ma, C.6
Surapaneni, S.7
-
11
-
-
84918819570
-
-
® Product Monograph cited 1 December, 2012
-
® Product Monograph, 2013. http://www.gsk.ca/english/docs-pdf/product-monographs/Avodart.pdf, cited 1 December, 2012.
-
(2013)
-
-
-
13
-
-
84907808559
-
A method to monitor dutasteride in rat plasma using liquid-liquid extraction and multiple reaction monitoring: Comparisons and validation
-
M.J. Kang, H.R. Cho, D.H. Lee, D.W. Yeom, Y.W. Choi, and Y.S. Choi A method to monitor dutasteride in rat plasma using liquid-liquid extraction and multiple reaction monitoring: comparisons and validation MSL 5 2014 79 83
-
(2014)
MSL
, vol.5
, pp. 79-83
-
-
Kang, M.J.1
Cho, H.R.2
Lee, D.H.3
Yeom, D.W.4
Choi, Y.W.5
Choi, Y.S.6
-
14
-
-
84878073007
-
Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures
-
M.S. Kim Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures Int. J. Nanomed. 8 2013 2029 2039
-
(2013)
Int. J. Nanomed.
, vol.8
, pp. 2029-2039
-
-
Kim, M.S.1
-
15
-
-
84878023073
-
Soluplus-coated colloidal silica nanomatrix system for enhanced supersaturation and oral absorption of poorly water-soluble drugs
-
M.S. Kim Soluplus-coated colloidal silica nanomatrix system for enhanced supersaturation and oral absorption of poorly water-soluble drugs Artif. Cells Nanomed. Biotechnol. 41 2013 363 367
-
(2013)
Artif. Cells Nanomed. Biotechnol.
, vol.41
, pp. 363-367
-
-
Kim, M.S.1
-
16
-
-
84894041999
-
Investigation of polymeric excipients for dutasteride solid dispersion and its physicochemical characterization
-
N.A. Kim, D.H. Choi, J.Y. Lim, K.H. Kim, D.G. Lim, E. Lee, E.-S. Park, and S.H. Jeong Investigation of polymeric excipients for dutasteride solid dispersion and its physicochemical characterization Arch. Pharm. Res. 37 2013 1 11
-
(2013)
Arch. Pharm. Res.
, vol.37
, pp. 1-11
-
-
Kim, N.A.1
Choi, D.H.2
Lim, J.Y.3
Kim, K.H.4
Lim, D.G.5
Lee, E.6
Park, E.-S.7
Jeong, S.H.8
-
18
-
-
0342561507
-
The effect of water-soluble polymers on aqueous solubility of drugs
-
T. Loftsson, H. Fririksdóttir, and T.K. Gumundsdóttir The effect of water-soluble polymers on aqueous solubility of drugs Int. J. Pharm. 127 1996 293 296
-
(1996)
Int. J. Pharm.
, vol.127
, pp. 293-296
-
-
Loftsson, T.1
Fririksdóttir, H.2
Gumundsdóttir, T.K.3
-
19
-
-
84878258812
-
Quality by design: Screening of critical variables and formulation optimization of Eudragit e nanoparticles containing dutasteride
-
S.J. Park, G.H. Choo, S.J. Hwang, and M.S. Kim Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride Arch. Pharm. Res. 36 2013 1 9
-
(2013)
Arch. Pharm. Res.
, vol.36
, pp. 1-9
-
-
Park, S.J.1
Choo, G.H.2
Hwang, S.J.3
Kim, M.S.4
-
20
-
-
0033805858
-
Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and 'self-microemusifying' drug delivery systems
-
C.W. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemusifying' drug delivery systems Eur. J. Pharm. Sci. 11 2000 93 98
-
(2000)
Eur. J. Pharm. Sci.
, vol.11
, pp. 93-98
-
-
Pouton, C.W.1
-
21
-
-
0036754256
-
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
-
C.G. Roehrborn, P. Boyle, J.C. Nickel, K. Hoefner, and G. Andriole Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia Urology 60 2002 434 441
-
(2002)
Urology
, vol.60
, pp. 434-441
-
-
Roehrborn, C.G.1
Boyle, P.2
Nickel, J.C.3
Hoefner, K.4
Andriole, G.5
-
22
-
-
84873718508
-
Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation
-
W.H. Song, J.H. Park, D.W. Yeom, B.K. Ahn, K.M. Lee, S.G. Lee, H.S. Woo, and Y.W. Choi Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation Arch. Pharm. Res. 36 2013 69 78
-
(2013)
Arch. Pharm. Res.
, vol.36
, pp. 69-78
-
-
Song, W.H.1
Park, J.H.2
Yeom, D.W.3
Ahn, B.K.4
Lee, K.M.5
Lee, S.G.6
Woo, H.S.7
Choi, Y.W.8
-
23
-
-
0030805738
-
Inhibitory effects of water soluble polymers on precipitation of RS-8359
-
F. Usui, K. Maeda, A. Kusai, K. Nishimura, and Y. Keiji Inhibitory effects of water soluble polymers on precipitation of RS-8359 Int. J. Pharm. 154 1997 59 66
-
(1997)
Int. J. Pharm.
, vol.154
, pp. 59-66
-
-
Usui, F.1
Maeda, K.2
Kusai, A.3
Nishimura, K.4
Keiji, Y.5
-
24
-
-
84884167268
-
Drug precipitation inhibitors in supersaturable formulations
-
S. Xu, and W.G. Dai Drug precipitation inhibitors in supersaturable formulations Int. J. Pharm. 453 2013 36 43
-
(2013)
Int. J. Pharm.
, vol.453
, pp. 36-43
-
-
Xu, S.1
Dai, W.G.2
-
25
-
-
24344461836
-
Hydrogen bonding interactions between adsorbed polymer molecules and crystal surface of acetaminophen
-
H. Wen, K.R. Morris, and K. Park Hydrogen bonding interactions between adsorbed polymer molecules and crystal surface of acetaminophen J. Colloid Interface Sci. 290 2005 325 335
-
(2005)
J. Colloid Interface Sci.
, vol.290
, pp. 325-335
-
-
Wen, H.1
Morris, K.R.2
Park, K.3
-
26
-
-
84889089518
-
Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension
-
K. Zhang, H. Yu, Q. Luo, S. Yang, X. Lin, Y. Zhang, B. Tian, and X. Tang Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension Eur. J. Pharm. Biopharm. 85 2013 1285 1292
-
(2013)
Eur. J. Pharm. Biopharm.
, vol.85
, pp. 1285-1292
-
-
Zhang, K.1
Yu, H.2
Luo, Q.3
Yang, S.4
Lin, X.5
Zhang, Y.6
Tian, B.7
Tang, X.8
|